NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosom...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
14.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and/or other glucosylceramide-based glycosphingolipids (GSLs).
La présente invention concerne des composés de formule I : et des sels pharmaceutiquement acceptables ou un promédicament de ceux-ci. La présente invention concerne également des compositions comprenant au moins un composé de formule I, et des procédés d'utilisation des composés de formule I pour le traitement ou la prophylaxie de maladies lysosomales, d'une maladie neurodégénérative, d'une maladie kystique, d'un cancer, ou de maladies ou de troubles associés à des taux élevés de glucosylcéramide (GlcCer), de glucosylsphingosine (GlcSph) et/ou d'autres glycosphingolipides à base de glucosylcéramide (GSL). |
---|---|
Bibliography: | Application Number: WO2023US14560 |